Plant ID: NPO5547
Plant Latin Name: Hypericum prolificum
Taxonomy Genus: Hypericum
Taxonomy Family: Hypericaceae
NCBI TaxonomyDB:
269015
Plant-of-the-World-Online:
n.a.
TSHR; | |
GPBAR1; | |
BLM; ALOX15; HSD17B10; AKR1B10; | |
PIM1; CSNK2A1; | |
NR1H4; | |
ESR1; ESR2; | |
HIF1A; | |
LMNA; |
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Cytochrome P450 family 2 | CYP2C9 | Cytochrome P450 2C9 | P11712 | CHEMBL3397 |
Cytochrome P450 family 3 | CYP3A4 | Cytochrome P450 3A4 | P08684 | CHEMBL340 |
Enzyme_unclassified | BLM | Bloom syndrome protein | P54132 | CHEMBL1293237 |
Enzyme_unclassified | ALOX15 | Arachidonate 15-lipoxygenase | P16050 | CHEMBL2903 |
Enzyme_unclassified | HSD17B10 | Endoplasmic reticulum-associated amyloid beta-peptide-binding protein | Q99714 | CHEMBL4159 |
Enzyme_unclassified | AKR1B10 | Aldo-keto reductase family 1 member B10 | O60218 | CHEMBL5983 |
Nuclear hormone receptor subfamily 1 group H | NR1H4 | Bile acid receptor FXR | Q96RI1 | CHEMBL2047 |
Nuclear hormone receptor subfamily 3 group A | ESR1 | Estrogen receptor alpha | P03372 | CHEMBL206 |
Nuclear hormone receptor subfamily 3 group A | ESR2 | Estrogen receptor beta | Q92731 | CHEMBL242 |
Peptide receptor (family A GPCR) | TSHR | Thyroid stimulating hormone receptor | P16473 | CHEMBL1963 |
Protein Kinase | PIM1 | Serine/threonine-protein kinase PIM1 | P11309 | CHEMBL2147 |
Protein Kinase | CSNK2A1 | Casein kinase II alpha | P68400 | CHEMBL3629 |
Small molecule receptor (family A GPCR) | GPBAR1 | G-protein coupled bile acid receptor 1 | Q8TDU6 | CHEMBL5409 |
Transcription Factor | HIF1A | Hypoxia-inducible factor 1 alpha | Q16665 | CHEMBL4261 |
Unclassified | LMNA | Prelamin-A/C | P02545 | CHEMBL1293235 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
MF | GO:0005488; binding | GO:0046914; transition metal ion binding | 3.949E-07 | 4.085E-03 | ALOX15, BLM, CYP2C9, CYP3A4, ESR1, ESR2, NR1H4, PIM1 |
MF | GO:0005488; binding | GO:0005496; steroid binding | 4.815E-07 | 4.085E-03 | CYP3A4, ESR1, ESR2, NR1H4 |
MF | GO:0060089; molecular transducer activity | GO:0038052; RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding | 5.629E-07 | 4.085E-03 | ESR1, ESR2 |
BP | GO:0008152; metabolic process | GO:0008202; steroid metabolic process | 8.881E-07 | 4.369E-03 | AKR1B10, CYP2C9, CYP3A4, ESR1, NR1H4 |
BP | GO:0009987; cellular process | GO:0038183; bile acid signaling pathway | 1.688E-06 | 5.250E-03 | GPBAR1, NR1H4 |
MF | GO:0060089; molecular transducer activity | GO:0038181; bile acid receptor activity | 1.688E-06 | 5.250E-03 | GPBAR1, NR1H4 |
MF | GO:0005488; binding | GO:0034056; estrogen response element binding | 3.374E-06 | 7.347E-03 | ESR1, ESR2 |
MF | GO:0003824; catalytic activity | GO:0034875; caffeine oxidase activity | 3.374E-06 | 7.347E-03 | CYP2C9, CYP3A4 |
BP | GO:0009987; cellular process | GO:0009755; hormone-mediated signaling pathway | 6.830E-06 | 1.063E-02 | ESR1, ESR2, NR1H4, TSHR |
BP | GO:0009987; cellular process | GO:0030522; intracellular receptor signaling pathway | 8.219E-06 | 1.147E-02 | ESR1, ESR2, NR1H4, PIM1 |
BP | GO:0008152; metabolic process | GO:0016098; monoterpenoid metabolic process | 8.428E-06 | 1.147E-02 | CYP2C9, CYP3A4 |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09100 Metabolism | 09103 Lipid metabolism | hsa00591 | Linoleic acid metabolism | 1.233E-06 | 6.286E-05 | CYP2C9, ALOX15, CYP3A4 |
09100 Metabolism | 09103 Lipid metabolism | hsa00590 | Arachidonic acid metabolism | 9.673E-04 | 9.544E-03 | CYP2C9, ALOX15 |
09100 Metabolism | 09108 Metabolism of cofactors and vitamins | hsa00830 | Retinol metabolism | 1.063E-03 | 9.544E-03 | CYP2C9, CYP3A4 |
09150 Organismal Systems | 09152 Endocrine system | hsa04917 | Prolactin signaling pathway | 1.302E-03 | 9.544E-03 | ESR1, ESR2 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00982 | Drug metabolism - cytochrome P450 | 1.196E-03 | 9.544E-03 | CYP2C9, CYP3A4 |
Unclassified | Unclassified | hsa01100 | Metabolic pathways | 1.610E-03 | 9.544E-03 | CYP2C9, AKR1B10, ALOX15, CYP3A4, HSD17B10 |
09150 Organismal Systems | 09154 Digestive system | hsa04976 | Bile secretion | 1.266E-03 | 9.544E-03 | NR1H4, CYP3A4 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 1.338E-03 | 9.544E-03 | CYP2C9, CYP3A4 |
09150 Organismal Systems | 09152 Endocrine system | hsa04915 | Estrogen signaling pathway | 2.442E-03 | 1.245E-02 | ESR1, ESR2 |
09160 Human Diseases | 09161 Cancers | hsa05204 | Chemical carcinogenesis | 1.684E-03 | 9.544E-03 | CYP2C9, CYP3A4 |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|